HC Wainwright Reiterates Buy Rating for Roivant Sciences (NASDAQ:ROIV)
HC Wainwright reiterated their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research note published on Monday,Benzinga reports. HC Wainwright currently has a $18.00 price objective on the stock. Separately, Cantor Fitzgerald upgraded Roivant Sciences to a “strong-buy” rating in a research note on Tuesday, March 4th. View Our Latest […]
HC Wainwright reiterated their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research note published on Monday,Benzinga reports. HC Wainwright currently has a $18.00 price objective on the stock. Separately, Cantor Fitzgerald upgraded Roivant Sciences to a “strong-buy” rating in a research note on Tuesday, March 4th. View Our Latest […]
